Latest "Pipeline Biotech A/S" News Stories

17:56 EDT 16th July 2018 | BioPortfolio

Here are the most relevant search results for "Pipeline Biotech A/S" found in our extensive news archives from over 250 global news sources.

More Information about Pipeline Biotech A/S on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pipeline Biotech A/S for you to read. Along with our medical data and news we also list Pipeline Biotech A/S Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pipeline Biotech A/S Companies for you to search.

Showing "Pipeline Biotech" News Articles 1–25 of 10,000+

Monday 16th July 2018

Key Considerations When Outsourcing Cell-Culture Medium Development

Today, cell-culture media for biological manufacturing represents a sizable market of more than $500M, but more impressive is...

Global Immunoassays Market Segmented by Technology, Therapeutics Area and End Users Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global Immunoassay market has been estimated to reach 17.16 billion in 2017. : The global Immunoassays market is expected to register a CAGR of 9.7% during the forecast period, 2018 to 2023. North America dominates the market due to the technological advancement in the immunoassay products and rising incidence in the chronic diseases like thyroid, cardiovascular diseases.High Sensitivity and S...

NanoSphere Health Sciences’ Brand Evolve Formulas Partners with Former NHL Star Jeff Friesen

NanoSphere Health Sciences (CSE:NSHS), the biotech firm behind the groundbreaking NanoSphere Delivery System™, has announced that its cannabis brand Evolve Formulas will partner with Jeff Friesen, former NHL player and marijuana advocate, in a campaign to educate athletes about the benefits of cannabis as a natural health supplement. The post NanoSphere Health Sciences’ Brand Evolve Formu...

Global Ascorbic Acid Market Segmented by Type, Source, Application and Geography 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The market accounted for USD 860.8 million in 2016 and is expected to reach USD 1103.15 million by 2023, registering a CAGR of 5.1% during the forecast period of 20182023.Ascorbic acid, with its salt derivatives, and ascorbyl palmitate is classified as food additives by the European Community and registered as Generally Recognized as Safe' GRAS substance by the US Food Drug Administration FDA, wh...

Surefire Medical Appoints Anil Singhal, PhD, to Its Board of Directors

Strengthens Oncology Drug Delivery Leadership Capabilities Surefire Medical, Inc. (Surefire) announced the appointment of Anil Singhal, PhD, to its board of directors, deepening its leadership capabilities in oncology. Anil currently serves as chief scientific officer for OncoResponse, a company focused on the development of therapeutic antibodi...

Otsuka has high hopes for its 'drug creation engine' acquisition

Otsuka is paying $430 million for a US clinical-stage biotech company it hopes will act as a ‘drug creation engine’ to accelerate its research into kidney diseases. Massachusetts-based Visterra designs and engineers antibody-based therapies in nep...

Ironwood Pharmaceuticals Initiates Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

– Trial designed to more comprehensively evaluate the effect of linaclotide 290 mcg on bothersome abdominal symptoms, including bloating, discomfort and pain, associated with IBS-C – Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial

Fusion Pharma Announces Formation of Advisory Board

Inaugural Advisory Board Includes Internationally Renowned Experts In Oncology and Radiation Therapy Fusion Pharmaceuticals, a biopharmaceutical company focused on radiotherapeutics (specifically, targeted alpha therapeutics), announced today the appointment of five internationally recognized clinician-scientists to its newly formed Advisory Board: Ros...

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

News from pharma, biotech and healthcare

Enanta Pharmaceuticals to Host Conference Call on August 7 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Third Quarter Ended June 30, 2018

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it plans to report its financial results for its fiscal third quarter ended June 30, 2018, after the U.S. markets close on August 7, 2018. Enanta manage...

Biopharma enters into research collaboration and licence agreement with biotech

Clinical-stage biopharmaceutical company, Immatics Biotechnologies, has entered into a research collaboration and licence agreement with international biotech company, Genmab, to develop next generation bispecific cancer immunotherapies.

Verge Genomics Announces $32 Million Series A to Lead Artificial Intelligence-Driven Drug Discovery

Led by DFJ, Series A Financing Unites Leading Life Sciences and Technology Investors to Support a Transformative Approach to Drug Development Verge Genomics, a drug discovery company utilizing machine learning to develop new therapeutics, announced today that it has raised $32 million in Series A financing led by DFJ. New biotech investors WuXi AppTec...

Biogen looking to expand into medtech: report

The biotech is considering how imaging and data technologies could bolster its position in neurology, according to the Israeli paper Globes. 

ProBioGen And Pionyr Initiate Second Antibody Therapeutics Development Project

NewsUnder the terms of the agreement, ProBioGen will perform process development and GMP manufacturing on a second antibody from the Pionyr pipeline using their high performance CHO.RiGHT expression platform.

Cassiopea prospects fill in as hair loss drug shows promise

The small biotech believes these results, while preliminary, show efficacy to compete with Propecia.

ASIT biotech (ASIT) - All go on Phase III

Edison Investment Research - Pharmaceutical & healthcare - ASIT Biotech: On July 11 ASIT biotech raised €12m in commitments in a heavily oversubscribed convertible bond placement. In raising this additional capital, ASIT outlined the primary use of the proceeds which is to fund the Phase III study of its short-course grass pollen allergy immunotherapy (AIT) product gp-ASIT+. An update was pro...

Verge Genomics Nabs $32M For Computation-Heavy Neuro Drug Discovery

Two years after making her first-ever rounds of business meetings at the J.P. Morgan healthcare conference, Alice Zhang has steered her biotech startup, Verge Genomics, into a $32 million Series A financing. Zhang (pictured) was notable then and now for her age—few biotech CEOs are under 30—and for her career path. She walked away from […]

#jobs #lifescience Celgene: Director, IT PMO R&D

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Celgene: Director, IT PMO R&D . Celgene: Other Locations:US- CA- San DiegoDescriptionCelgene is a global biopharmaceutical company leading the way in medical innovation to help patients live San … Continue reading → Cet article #jobs #lifescience Celgene: Dire...

#jobs #lifescience Celgene: Director QA, Biologics Development

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Celgene: Director QA, Biologics Development . Celgene: Other Locations:US- NJ- Summit WestDescriptionCelgene is a global biopharmaceutical company leading the way in medical innovation to help patients liv Summit, … Continue reading → Cet article #jobs #lifescience...

#jobs #lifescience Celgene: Senior Manager, Global Marketing Project Management

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Celgene: Senior Manager, Global Marketing Project Management . Celgene: Other Locations:US- NJ- Summit EastDescriptionCelgene is a global biopharmaceutical company leading the way in medical innovation to help patients … Continue reading → Cet article #jobs #lifesc...

Acron Medical Announces FDA 510(k) Clearance of its Signature PEEK TLIF Interbody System, the ACRON Interbody.

The Acron TLIF is the solution of choice for osteoporotic patients with lower back pain in need of a spinal fusion ORLANDO (PRWEB) July 16, 2018 Acron Medical, LLC (, part of the spineMED Group, is a spine technology organization, dedicated to developing and commercializing globally innovative spinal implants. The company is proud to announce that it has received 510(...

Biotech Entrepreneur, 29, Raises $32 Million To Use AI To Develop Drugs For Parkinson's, ALS

Alice Zhang was a graduate student at UCLA when she decided that there was a tremendous opportunity to speed up the process of drug development. "We could start taking the guesswork out of drug discovery."

This Week's Biotech IPOs

The IPO activity in the U.S. pharma/biotech sector had a strong showing last quarter (Q2) with 24 listings compared to 13 in the year-ago period. There has not been a single biotech IPO for the month of July so far. But that is about to change.

#news #biotech Urovant launches US150m IPO

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Urovant launches US150m IPO . from European Biotechnology – first and foremost in European biotech Cet article #news #biotech Urovant launches US150m IPO est apparu en premier sur Biotech 365.

#jobs #lifescience Project Management Consultants

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Project Management Consultants .IL-Burr Ridge, Project Management Consultants for Integrated Project Management Company, Inc to report to our Burr Ridge, IL HQ but work at multiple unanticipated locations … Continue reading → Cet article #jobs #lifescience Project ...

Quick Search


News Quicklinks